Riverview Village: Medical Records Violation - IN
The documentation failures involved Tramadol, a prescription narcotic pain reliever, given to residents with conditions including osteoarthritis, restless leg syndrome, diabetes and hypertension. Staff signed medication records showing they dispensed the controlled substance but failed to record administration on required tracking documents.
Resident C was prescribed Tramadol 50 milligrams every six hours for pain — doses scheduled at 8:00 a.m., 2:00 p.m., 8:00 p.m. and 2:00 a.m. according to physician orders dated May 19. Inspectors found the controlled substance record showed nurses administered the medication six times in October and November: October 3 at 8:00 p.m., October 30 at 2:00 a.m., November 1 at 2:00 a.m., November 5 at 8:00 p.m., November 7 at 8:00 p.m., and November 11 at 8:00 a.m.
None of those administrations appeared on the resident's medication administration record.
Licensed Practical Nurse 5 told inspectors on November 20 that when narcotic pain medication is administered, nurses should sign both the controlled substance record and the medication administration record. The facility's own policy, updated in November 2024, requires controlled substances to be "recorded" and states that "when a controlled substance is administered to a resident, it must be recorded in the residents Medication Administration Record."
Resident F experienced similar documentation gaps with the same medication. This resident was prescribed Tramadol 50 milligrams three times daily for pain at 8:00 a.m., 2:00 p.m. and 8:00 p.m., according to October 1 physician orders.
The tracking discrepancies for Resident F created a confusing pattern. On October 1 at 8:00 p.m., staff signed the controlled substance record showing administration but left the medication administration record blank. The same thing happened October 10 at 8:00 a.m.
Then the pattern reversed. On October 11 at 2:00 p.m., staff documented administration on the medication record but not the controlled substance record. This happened again November 7 at 2:00 p.m. and November 10 at 2:00 p.m.
The Director of Nursing provided inspectors with the facility's controlled substances policy during the November 20 investigation. The document, titled "Controlled Substances: Storage, Documentation, Inventory and Destruction (Includes Fentanyl Patch Removal and Destruction)," clearly outlined documentation requirements that staff were not following.
Federal regulations require nursing homes to maintain accurate medical records that reflect the administration of medications, particularly controlled substances subject to strict tracking requirements. The failures at Riverview Village meant administrators could not verify whether residents actually received prescribed pain medication or account for narcotic inventory.
Inspectors reviewed three residents' medication records during the complaint investigation and found documentation problems with two of them. The inspection report classified the violation as causing minimal harm or potential for actual harm to few residents.
The medication administration gaps occurred despite clear facility policies requiring dual documentation. Staff demonstrated they knew how to complete the controlled substance records — they signed those documents multiple times. They also knew how to complete medication administration records, signing those for some doses.
But they failed to complete both records consistently, creating holes in the documentation trail for a controlled substance. The inconsistent record-keeping meant facility administrators could not reconcile narcotic inventory or verify that residents received prescribed pain relief.
Tramadol, while considered less potent than other opioid pain medications, remains a controlled substance requiring careful tracking under federal law. The medication helps manage chronic pain conditions like the osteoarthritis affecting Resident C.
The inspection occurred in response to a complaint, though the report does not specify what prompted the federal investigation. Inspectors completed their review on November 20, documenting the medication record failures that affected residents' pain management documentation.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Riverview Village from 2025-11-20 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
RIVERVIEW VILLAGE in CLARKSVILLE, IN was cited for violations during a health inspection on November 20, 2025.
Staff signed medication records showing they dispensed the controlled substance but failed to record administration on required tracking documents.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.